Home › Companies › Biometrics, Biotechnology, Health Care, Health Diagnostics, Life Science, Medical › Teiko.bio

Teiko.bio

Teiko.bio is an immune profiling platform that enables clinicians to make informed decisions around patient response.

Operating in biometrics, biotechnology, health care, health diagnostics, life science, medical based in Western US, Teiko.bio was founded in 2020.

The company sits in the biometrics, biotechnology, health care, health diagnostics, life science, medical segment, where it competes on its core product or service.

Its base of operations is Western US.

It is recorded at the Seed stage.

The company reports a headcount in the c_00001_00010 range.

Total disclosed funding stands at about $11.6M.

Sector	Biometrics, Biotechnology, Health Care, Health Diagnostics, Life Science, Medical
Headquarters	Western US
Founded	2020
Employees	c_00001_00010
Stage	seed
Total funding	$11,639,995

Website: teiko.bio

Teiko.bio

Browse related